Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kannel WB, Abbott RD, Savage DD et al (1982) Epidemiologic features of chronic atrial fibrillation: the Framingham Study. N Engl J Med 306:1018–1022
Krahn AD, Manfreda J, Tate RB et al (1995) The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 98:476–484
Khand AU, Rankin AC, Kaye GC et al (2000) Systematic review of the management of atrial fibrillation in patients with heart failure. Eur Heart J 21:614–632
Go AS, Hylek EM, Phillips KA et al (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285:2370–2375
Benjamin EJ, Levy D, Vaziri SM et al (1994) Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 16:840–844
Lloyd-Jones DM, Wang TJ, Leip EP et al (2004) Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 110:1042–1046
Lloyd-Jones DM, Larson MG, Leip EP et al (2002) Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 106:3068–3072
Badano LP, Di Lenarda A, Bellotti P et al (2003) Patients with chronic heart failure encountered in daily clinical practice are different from the ‘typical’ patient enrolled in therapeutic trials. Ital Heart J 4:84–91
Cleland JG, Swedberg K, Follath F et al (2003) The EuroHeart Failure survey programme: a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 24:442–463
Middlekauff HR, Stevenson WG, Stevenson LW (1991) Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation 84:40–48
Savelieva I, Camm AJ (2004) Atrial fibrillation and heart failure: natural history and pharmacological treatment. Europace 5:S5–S19
Grogan M, Smith HC, Gersh BJ et al (1992) Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Car diol 69:1570–1573
Shinbane JS, Wood MA, Jensen DN et al (1997) Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol 29:709–715
Boriani G, Biffi M, Rapezzi C et al (2003) Late improvement in ventricular performance following internal cardioversion for persistent atrial fibrillation: an argument in support of concealed cardiomyopathy. Pacing Clin Electrophysiol 26:1218–1226
Boriani G, Biffi M, Diemberger I et al (2003) Rate control in atrial fibrillation: choice of treatment and assessmen t of efficacy. Drugs 63:1489–1509
Van Den Berg MP, Tuinenburg AE, Crijns HJGM et al (1997) Heart failure and atrial fibrillation: current concepts and controversies. Heart 77:309–313
Wang TJ, Larson MG, Levy D et al (2003) Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 107:2920–2925
Dries DL, Exner DV, Gersh BJ et al (2001) Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 32:695–703
Pedersen OD, Bagger H, Keller N et al (2001) Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (Diamond) substudy. Circulation 104:292–296
Wolff PA, Mitchell JB, Baker CS et al (1995) Mortality and hospital costs associated with atrial fibrillation. Circulation 92:I–140 (abs)
Berry C, Murdoch DR, McMurray JJ (2001) Economics of chronic heart failure. Eur J Heart Fail 3:283–291
Boriani G, Biffi M, Camanini C et al (2004) Efficacy of internal cardioversion for chronic atrial fibrillation in patients with and without left ventricular dysfunction. Int J Cardiol 95:43–47
Boriani G, Diemberger I, Biffi M et al (2004) Pharmacological cardioversion of atrial fibrillation: current management and treatment options. Drugs 64:2741–2762
Hsu LF, Jaïs P, Sanders P et al (2004) Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 351:2373–2383
Jessup M, Brozena S (2003) Heart failure. N Engl J Med 348:2007–2018
Boriani G, Biffi M, Martignani C et al (2004) Cardiac resynchronization by pacing: an electrical treatment of heart failure. Int J Cardiol 94:151–161
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Italia
About this chapter
Cite this chapter
Boriani, G. et al. (2006). Atrial Fibrillation and Heart Failure: Does One Epidemic Feed the Other?. In: Raviele, A. (eds) Cardiac Arrhythmias 2005. Springer, Milano. https://doi.org/10.1007/88-470-0371-7_9
Download citation
DOI: https://doi.org/10.1007/88-470-0371-7_9
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0370-5
Online ISBN: 978-88-470-0371-2
eBook Packages: MedicineMedicine (R0)